Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.

Yutaka Yamazaki, Itsuo Chiba, Atsuko Hirai, Ken ichi Notani, Haruhiko Kashiwazaki, Kanchu Tei, Yasunori Totsuka, Tadashi Iizuka, Takao Kohgo, Hiroshi Fukuda

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Reliable variables to predict the radiosensitivity of each tumor have not been identified. Recent studies have demonstrated that specific regions of mutations within the core domain of p53 protein correlate with responses to chemotherapy and radiotherapy in some tumor types. In this study, we evaluated the relationship between specific p53 mutations and radiosensitivity in 49 patients with oral squamous cell carcinomas (SCCs) who underwent preoperative radiotherapy. Exons 5 through 8 of the p53 gene were examined by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing. We detected p53 mutations in 27 (55.1%) cases. DNA contact mutations were detected in 11 (40.7%) of these 27 cases in L3 loop, loop-sheet-helix motif, and zinc-binding residues. Tumors containing p53 DNA contact mutations had significantly poorer responses to radiation than the other tumors, although no statistically significant difference between tumors with and without p53 mutations was found. These data indicate that DNA contact mutation of p53 could be a useful marker to predict the radioresistance of oral SCCs.

Original languageEnglish
JournalAmerican journal of clinical oncology
Volume26
Issue number5
Publication statusPublished - Jan 1 2003
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Mutation
DNA
Radiation Tolerance
Neoplasms
Radiotherapy
p53 Genes
Zinc
Exons
Radiation
Drug Therapy
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Yamazaki, Y., Chiba, I., Hirai, A., Notani, K. I., Kashiwazaki, H., Tei, K., ... Fukuda, H. (2003). Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation. American journal of clinical oncology, 26(5).

Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation. / Yamazaki, Yutaka; Chiba, Itsuo; Hirai, Atsuko; Notani, Ken ichi; Kashiwazaki, Haruhiko; Tei, Kanchu; Totsuka, Yasunori; Iizuka, Tadashi; Kohgo, Takao; Fukuda, Hiroshi.

In: American journal of clinical oncology, Vol. 26, No. 5, 01.01.2003.

Research output: Contribution to journalArticle

Yamazaki, Y, Chiba, I, Hirai, A, Notani, KI, Kashiwazaki, H, Tei, K, Totsuka, Y, Iizuka, T, Kohgo, T & Fukuda, H 2003, 'Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.', American journal of clinical oncology, vol. 26, no. 5.
Yamazaki, Yutaka ; Chiba, Itsuo ; Hirai, Atsuko ; Notani, Ken ichi ; Kashiwazaki, Haruhiko ; Tei, Kanchu ; Totsuka, Yasunori ; Iizuka, Tadashi ; Kohgo, Takao ; Fukuda, Hiroshi. / Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation. In: American journal of clinical oncology. 2003 ; Vol. 26, No. 5.
@article{32c9aae855d842e0984865b5d95521b6,
title = "Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.",
abstract = "Reliable variables to predict the radiosensitivity of each tumor have not been identified. Recent studies have demonstrated that specific regions of mutations within the core domain of p53 protein correlate with responses to chemotherapy and radiotherapy in some tumor types. In this study, we evaluated the relationship between specific p53 mutations and radiosensitivity in 49 patients with oral squamous cell carcinomas (SCCs) who underwent preoperative radiotherapy. Exons 5 through 8 of the p53 gene were examined by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing. We detected p53 mutations in 27 (55.1{\%}) cases. DNA contact mutations were detected in 11 (40.7{\%}) of these 27 cases in L3 loop, loop-sheet-helix motif, and zinc-binding residues. Tumors containing p53 DNA contact mutations had significantly poorer responses to radiation than the other tumors, although no statistically significant difference between tumors with and without p53 mutations was found. These data indicate that DNA contact mutation of p53 could be a useful marker to predict the radioresistance of oral SCCs.",
author = "Yutaka Yamazaki and Itsuo Chiba and Atsuko Hirai and Notani, {Ken ichi} and Haruhiko Kashiwazaki and Kanchu Tei and Yasunori Totsuka and Tadashi Iizuka and Takao Kohgo and Hiroshi Fukuda",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "26",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.

AU - Yamazaki, Yutaka

AU - Chiba, Itsuo

AU - Hirai, Atsuko

AU - Notani, Ken ichi

AU - Kashiwazaki, Haruhiko

AU - Tei, Kanchu

AU - Totsuka, Yasunori

AU - Iizuka, Tadashi

AU - Kohgo, Takao

AU - Fukuda, Hiroshi

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Reliable variables to predict the radiosensitivity of each tumor have not been identified. Recent studies have demonstrated that specific regions of mutations within the core domain of p53 protein correlate with responses to chemotherapy and radiotherapy in some tumor types. In this study, we evaluated the relationship between specific p53 mutations and radiosensitivity in 49 patients with oral squamous cell carcinomas (SCCs) who underwent preoperative radiotherapy. Exons 5 through 8 of the p53 gene were examined by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing. We detected p53 mutations in 27 (55.1%) cases. DNA contact mutations were detected in 11 (40.7%) of these 27 cases in L3 loop, loop-sheet-helix motif, and zinc-binding residues. Tumors containing p53 DNA contact mutations had significantly poorer responses to radiation than the other tumors, although no statistically significant difference between tumors with and without p53 mutations was found. These data indicate that DNA contact mutation of p53 could be a useful marker to predict the radioresistance of oral SCCs.

AB - Reliable variables to predict the radiosensitivity of each tumor have not been identified. Recent studies have demonstrated that specific regions of mutations within the core domain of p53 protein correlate with responses to chemotherapy and radiotherapy in some tumor types. In this study, we evaluated the relationship between specific p53 mutations and radiosensitivity in 49 patients with oral squamous cell carcinomas (SCCs) who underwent preoperative radiotherapy. Exons 5 through 8 of the p53 gene were examined by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing. We detected p53 mutations in 27 (55.1%) cases. DNA contact mutations were detected in 11 (40.7%) of these 27 cases in L3 loop, loop-sheet-helix motif, and zinc-binding residues. Tumors containing p53 DNA contact mutations had significantly poorer responses to radiation than the other tumors, although no statistically significant difference between tumors with and without p53 mutations was found. These data indicate that DNA contact mutation of p53 could be a useful marker to predict the radioresistance of oral SCCs.

UR - http://www.scopus.com/inward/record.url?scp=1542568565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542568565&partnerID=8YFLogxK

M3 - Article

C2 - 14528086

AN - SCOPUS:1542568565

VL - 26

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 5

ER -